Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 200 #1
TickerRNA [NASD]
CompanyProsensa Holding N.V.
Market Cap729.13MEPS (ttm)-0.34
P/E-EPS this Y-36.20%
Forward P/E-EPS next Y-115.00%
PEG-EPS past 5Y0.00%
P/S30.51EPS next 5Y-
P/B9.15EPS Q/Q-40.00%
Dividend-Sales Q/Q-
Insider Own-Inst Own84.40%
Insider Trans-Inst Trans1.26%
Short Float6.32%EarningsNov 17
Analyst Recom1.90Target Price13.94
Avg Volume328.11K52W Range4.03 - 18.99
Nov-28-14 04:39AMProsensa Holding N.V. (RNA) Jumps: Stock Rises 8.6% Zacks
Nov-25-14 07:00PMINVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Prosensa Holding N.V. (RNA) Over the Proposed Sale of the Company to BioMarin Pharmaceutical Inc. Business Wire
Nov-25-14 08:45AMProsensa Holding downgraded by ROTH Capital
Nov-24-14 05:04PMSHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Prosensa Holding N.V. And Encourages Investors To Contact The Firm For Additional Information Business Wire
Nov-24-14 04:49PMUS STOCKS-S&P 500 ticks up to record on central bank bets Reuters
Nov-24-14 03:19PMUS STOCKS-Wall St up on central bank bets, deals support Reuters
Nov-24-14 12:34PMUS STOCKS-Wall St hits new records, but telecom weighs on Dow Reuters
Nov-24-14 12:20PMBioMarin's Prosensa Buy: A 'Courageous' Acquisition? at
Nov-24-14 11:33AMPROSENSA SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by BioMarin May be Unfair to Shareholders Business Wire
Nov-24-14 11:18AMUS STOCKS-Wall St hits new records, boosted by cyclicals Reuters
Prosensa Holding N.V., a biotechnology company, engages in the discovery and development of ribonucleic acid-modulating therapeutics for the treatment of genetic disorders. The company's products focus on the treatment of neuromuscular and neurodegenerative disorders, including duchenne muscular dystrophy (DMD), myotonic dystrophy, and huntington's diseases. It develops drisapersen, which is in Phase III studies to restore dystrophin expression and enhancing muscle condition; PRO044 that is in Phase I/II studies to address a separate sub-population of DMD patients; and PRO045, PRO053, PRO052, and PRO055 to address other distinct sub-populations of DMD patients. The company also develops PRO135 that is in preclinical trials for myotonic dystrophy; PRO289, which is in preclinical trials for treating huntington's diseases; and PROSPECT for the rare mutations. Prosensa Holding N.V. was incorporated in 1997 and is based in Leiden, the Netherlands.
TickerLFC [NYSE]
CompanyChina Life Insurance Co. Ltd.
IndustryLife Insurance
Market Cap91.43BEPS (ttm)2.34
P/E22.39EPS this Y124.00%
Forward P/E19.02EPS next Y8.04%
PEG1.82EPS past 5Y5.30%
P/S1.36EPS next 5Y12.30%
P/B2.51EPS Q/Q22.10%
Dividend1.34%Sales Q/Q47.60%
Insider Own-Inst Own1.10%
Insider Trans-Inst Trans-3.23%
Short Float0.08%EarningsMar 16
Analyst Recom1.00Target Price53.46
Avg Volume168.06K52W Range37.63 - 48.77
Nov-28-14 05:40AMWill China Life Insurance (LFC) Continue to Surge Higher? Zacks
Nov-25-14 05:52AMWhy Genworth (GNW) Could Be Positioned for a Slump Zacks
Nov-21-14 04:51PMPrimerica (PRI) Gains on New Share Repurchase Program Zacks
Nov-13-14 03:00PMProtective Life Hits 52-Week High on Strong Q3 Earnings Zacks
Nov-13-14 02:50PMStanCorp Boosts Shareholder Value with 18% Dividend Hike Zacks
Nov-12-14 11:30AMLincoln National Hits 52-Week High Post Solid Q3 Earnings Zacks
Nov-12-14 06:25AMHealth Insurance Innovations (HIIQ) in Focus: Stock Tumbles 18.3% Zacks
Nov-04-14 09:25AMReinsurance Group Hits 52-Week High on Strong Q3 Results Zacks
Oct-30-14 01:00PMLincoln National Earnings Beat on Expansion of Products Zacks
Oct-30-14 10:56AMChina Stock Roundup: Baidu Beats, PetroChina Misses Zacks
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in China. The company's Individual Life Insurance Business segment sells long-term life insurance and universal life contracts, including term life, whole life, endowment, and annuity products to individuals. Its Group Life Insurance Business segment offers insurance contracts and investment contracts, such as term life, whole life, and annuity products to group entities. The company's Short-Term Insurance Business segment provides short-term insurance contracts, including short-term accident and health insurance contracts. Its Supplementary Major Medical Insurance Business segment sells supplementary major medical insurance contracts to urban and rural residents. China Life Insurance Company Limited offers its products through agents, direct sales representatives, dedicated and non-dedicated agencies, and intermediary bancassurance outlets. The company was founded in 1949 and is headquartered in Beijing, China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company.
CompanyTASER International Inc.
IndustryAerospace/Defense Products & Services
Market Cap1.15BEPS (ttm)0.37
P/E59.11EPS this Y25.90%
Forward P/E46.53EPS next Y22.40%
PEG1.97EPS past 5Y41.50%
P/S7.28EPS next 5Y30.00%
P/B9.72EPS Q/Q40.00%
Dividend-Sales Q/Q25.90%
Insider Own2.10%Inst Own69.00%
Insider Trans-10.69%Inst Trans0.96%
Short Float16.56%EarningsOct 30/b
Analyst Recom2.20Target Price20.20
Avg Volume3.03M52W Range10.46 - 21.01
Nov-27-14 07:31AM7:31 am TASER announced the purchase of 623 AXON body-worn video cameras and a five-year subscription to by the Winston-Salem Police Department
Nov-26-14 04:11PMTaser Shares Spike After A Police Department Places An Order For Body Cameras Business Insider
Nov-26-14 01:22PMPost-Ferguson, more police uniforms include cameras at
Nov-26-14 11:58AMTaser Nears 10-Year High As Camera Orders Rise at Investor's Business Daily
Nov-26-14 11:47AMJohn Deere stalls, Lakeland comes back to Earth, Taser surges Yahoo Finance
Nov-26-14 08:40AMTaser's stock rallies after order for body-worn cameras at MarketWatch
Nov-26-14 07:30AMWinston-Salem Police Department Moves to Full Deployment of AXON Body Cameras With Additional Purchase of 623 Cameras From TASER Marketwired
Nov-25-14 06:50PMFerguson gooses Taser stock Investor's Business Daily
Nov-25-14 01:29PMStocks Turn Mildly Higher; Taser, Qihoo Gain at Investor's Business Daily
Nov-25-14 12:55PMMid-Day Market Update: Dycom Jumps On Upbeat Results; Amira Nature Foods Shares Slip Benzinga
TASER International, Inc. is engaged in the development, manufacture, and sale of conducted electrical weapons (CEWs) for use in law enforcement, federal, military, corrections, private security, and personal defense markets worldwide. Its CEWs transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. The company manufactures four hand-held CEW product lines, including TASER X26P, TASER X2, TASER X26, and TASER M26; and TASER eXtended Range Electronic Projectile, a self-contained wireless CEW that deploys from a 12-gauge pump-action shotgun. It also offers consumer products comprising TASER C2 CEW; the TASER StrikeLight, a handheld stun device, integrated with a flashlight; various types of cartridges comprising standard cartridges, Smart cartridges, training cartridges, and others; and other accessories, such as batteries. In addition, the company provides video products, including AXON system that utilizes advanced audio-video record and capture devices worn by first responders to record video of critical incidents from the visual perspective of the officer; the AXON body camera, a body worn camera for law enforcement; EVIDENCE.COM, a cloud-based digital evidence management system and warehouse, offering digital evidence management, sharing, analysis, and storage; and the TASER Cam HD, a video recording device that captures both video and audio of potential and actual TASER use incidents as an accessory to a TASER CEW. TASER International, Inc. sells its products through its direct sales force, distribution partners, online store, and third-party resellers. The company was founded in 1993 and is headquartered in Scottsdale, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Behrendt Daniel MarcChief Financial OfficerNov 21Option Exercise5.6425,300142,69286,907Nov 24 05:16 PM
GARNREITER MICHAELDirectorNov 12Sale20.004,00080,00017,292Nov 13 04:42 PM
Kukowski JeffChief Operating OfficerNov 11Option Exercise4.3215,00064,80054,825Nov 12 04:09 PM
Larson LukeChief Marketing OfficerNov 06Sale18.466,728124,19938,666Nov 06 05:55 PM
Behrendt Daniel MarcChief Financial OfficerNov 03Option Exercise6.4990,576587,863162,183Nov 03 06:01 PM
CompanyMGP Ingredients Inc.
IndustryProcessed & Packaged Goods
Market Cap256.66MEPS (ttm)0.90
P/E16.17EPS this Y-477.80%
Forward P/E-EPS next Y-
PEG-EPS past 5Y39.40%
P/S0.82EPS next 5Y-
P/B2.60EPS Q/Q191.90%
Dividend0.34%Sales Q/Q-3.40%
Insider Own1.40%Inst Own25.20%
Insider Trans35.72%Inst Trans21.08%
Short Float1.74%EarningsMar 13/a
Analyst Recom-Target Price13.24
Avg Volume76.73K52W Range4.71 - 13.90
Nov-21-14 01:04PMMGP INGREDIENTS INC Financials EDGAR Online Financials
Nov-16-14 07:08PM10-Q for MGP Ingredients, Inc. Company Spotlight
Nov-13-14 06:03AMMGP INGREDIENTS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina EDGAR Online
Nov-12-14 06:40PMMGP Ingredients, Inc. Reports Third Quarter 2014 Results GlobeNewswire
Nov-05-14 03:29PMMGP Supports Lawrenceburg Heritage With Limited Edition Bourbon Whiskey GlobeNewswire
Sep-30-14 06:52AMLawsuit against Templeton Rye maker gets green light at USA TODAY
Sep-29-14 10:31AMMGP Expands Schrick's Role to Support Growth GlobeNewswire
Sep-10-14 09:54AMMGP Offers Non-GMO Proteins and Starches GlobeNewswire
Aug-12-14 06:01AMMGP INGREDIENTS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Aug-07-14 05:05PMMGP INGREDIENTS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina EDGAR Online
MGP Ingredients, Inc. produces and sells distillery and ingredients products to the packaged goods industry in the United States, Japan, and Canada. Its Distillery Products segment primarily offers food grade alcohol, fuel grade alcohol, and distillers feed. The company's Ingredient Solutions segment primarily provides specialty wheat starches and proteins, commodity wheat starches, and commodity vital wheat gluten. MGP Ingredients, Inc. sells its products directly or through distributors to the manufacturers and processors of finished packaged goods or to bakeries. The company was founded in 1941 and is headquartered in Atchison, Kansas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STRANDJORD M JEANNINEDirectorNov 18Buy12.375,00061,85010,000Nov 20 03:20 PM
Bridendall John PDirectorNov 17Buy12.4820,000249,60045,041Nov 19 05:36 PM
Griffin Augustus C.President and CEONov 17Buy12.332,00024,66031,400Nov 19 05:33 PM
Page George W JrDirectorSep 15Buy10.594,00042,36012,000Sep 16 07:03 PM
Griffin Augustus C.President and CEOSep 12Buy12.262,40029,43029,400Sep 16 06:53 PM
CompanyMIND C.T.I., Ltd.
IndustryInformation Technology Services
Market Cap79.17MEPS (ttm)0.21
P/E19.90EPS this Y-47.80%
Forward P/E-EPS next Y-
PEG-EPS past 5Y19.10%
P/S3.67EPS next 5Y-
P/B4.14EPS Q/Q300.00%
Dividend5.74%Sales Q/Q43.20%
Insider Own30.51%Inst Own13.20%
Insider Trans-Inst Trans3.01%
Short Float0.23%EarningsMay 05
Analyst Recom-Target Price-
Avg Volume232.03K52W Range1.65 - 3.95
Nov-03-14 07:11AMMIND CTI Reports Third Consecutive Quarter of Record Revenues Marketwired
Sep-24-14 07:18AM5 Stocks Under $10 Making Big Moves Higher at TheStreet
Aug-06-14 10:24AMMIND CTI Reports New Record Quarterly Revenues of $6.3 Million Marketwired
Jun-23-14 06:53AMMIND C.T.I. reports new win and two major follow-on orders
Jun-23-14 06:51AMMIND CTI Reports New Win and Two Major Follow-On Orders Marketwired
Jun-02-14 11:30AM3 Buy-Rated Dividend Stocks Leading The Pack: AI, CFFN, MNDO at TheStreet
May-22-14 11:30AMTop 3 Yielding Buy-Rated Stocks: AI, MNDO, CRT at TheStreet
May-12-14 11:30AMTop 3 Yielding Buy-Rated Stocks: AI, BKCC, MNDO at TheStreet
May-12-14 08:34AMMIND CTI Reports Record Quarterly Revenues of $5.7 Million Marketwired
Apr-18-14 01:04PMMIND CTI LTD Financials EDGAR Online Financials
MIND C.T.I. Ltd., together with its subsidiaries, develops, manufactures, and markets real-time and off-line billing and customer care software in the Americas, the Asia Pacific, Africa, Europe, and Israel. The company offers billing and customer care solution supports services, such as voice, data, and content services, as well as prepaid and postpaid payment models in a single platform. It also provides workflow engine to support the creation and execution of business processes, including order management, trouble ticket, and debt collection, as well as integral point of sale solution that covers all dealer, store and cashier management, and sales processes. In addition, the company offers professional services comprising installation, turnkey project implementation services, customer support, training and maintenance services, customization, and project management, as well as managed services, including day to day billing operational tasks primarily to billing and customer care customers. Further, it provides call management systems comprising PhonEX, MEIPS, PhonEX-Ten, and PhonEX-ONE used by organizations for call accounting, telecom expense management, traffic analysis, and fraud detection. The company offers its products directly; and through vendors, systems integrators, and resellers primarily to communication providers, such as traditional wireline and wireless, voice over IP, and broadband IP network operators, as well as through WiMAX, cable, 3G / 4G, and mobile virtual network operators. MIND C.T.I. Ltd. was founded in 1995 and is headquartered in Yokneam Illit, Israel.
CompanyKeysight Technologies, Inc.
IndustryScientific & Technical Instruments
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E13.20EPS next Y-6.20%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B-EPS Q/Q-3.60%
Dividend-Sales Q/Q8.00%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom2.30Target Price35.50
Avg Volume3.90M52W Range27.32 - 33.11
Nov-26-14Initiated Robert W. Baird Outperform $41
Nov-26-14 06:33AMCoverage initiated on Keysight by Robert W. Baird
Nov-25-14 11:00AMKeysight Technologies to Present at Credit Suisse 2014 Annual Technology Conference Business Wire
Nov-21-14 11:11PMDow, S&P 500 Hit New Highs for the Week at
Nov-20-14 11:00AMTRADE NEWS: Keysight Technologies Selected by Sharp Communications for Bluetooth Qualified Test Facility Business Wire
Nov-18-14 11:00AMTRADE NEWS: Keysight Technologies Demonstrates LTE-Advanced 450 Mbps End-to-End IP Data Throughput with UXM Wireless Test Set Business Wire
Nov-17-14 04:07PMKEYSIGHT TECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
Nov-17-14 04:05PMKeysight Technologies Reports Fourth-Quarter 2014 Results Business Wire
Nov-14-14 09:50AMWill Agilent Technologies (A) Miss Q4 Earnings Estimates? Zacks
Nov-12-14 11:16AMDanaher Upgraded As Analyst Pushes Agilent Buyout at Investor's Business Daily
Nov-11-14 03:26PMKeysight Technologies (KEYS) Stock Higher Today After Announcing Multi-Vendor Capability at TheStreet
Keysight Technologies, Inc. provides electronic measurement solutions to the communications and electronics industries in the United States and internationally. It operates through two segments: Measurement Solutions, and Customer Support and Services. The Measurement Solutions segment sells radio frequency and microwave test instruments and related software, and electronic design automation software tools for use in wireless, and aerospace and defense applications; digital test products that are used by research and development engineers; and voltmeters, multimeters, frequency counters, bench and system power supplies, function generators, and waveform synthesizers, as well as related software that are used by engineers in research and development laboratories. This segment also offers semiconductor and board test solutions, such as parametric test instruments and systems, in-circuit test systems, and laser interferometer measurement systems; surveillance systems and subsystems comprising probes for detecting signals and software, which are used by defense and government engineers and technicians; fiber optic test products, including optical modulation analyzers, component analyzers, power meters, and laser source products; and atomic force and scanning electron microscopes. The Customer Support and Services segment provides repair and calibration services for its customers' installed base of instruments; offers parts and self-maintenance tools; and facilitates the resale of refurbished used equipment. The company sells its products through direct sales force, distributors, resellers, and manufacturer's representatives. Keysight Technologies, Inc. was incorporated in 2013 and is headquartered in Santa Rosa, California. Keysight Technologies, Inc. (NYSE:KEYS.WI) operates independently of Agilent Technologies Inc. as of November 03, 2014.
CompanyNorthfield Bancorp, Inc.
IndustryRegional - Northeast Banks
Market Cap697.48MEPS (ttm)0.39
P/E36.51EPS this Y17.20%
Forward P/E31.43EPS next Y10.49%
PEG2.43EPS past 5Y5.50%
P/S7.73EPS next 5Y15.00%
P/B1.10EPS Q/Q11.10%
Dividend1.97%Sales Q/Q-3.00%
Insider Own3.70%Inst Own52.50%
Insider Trans68.70%Inst Trans-0.76%
Short Float4.58%EarningsJan 24/a
Analyst Recom3.00Target Price15.00
Avg Volume265.12K52W Range12.03 - 14.38
Nov-25-14 09:53AMNorthfield Bancorp (NFBK) Is Today's Strong And Under The Radar Stock at TheStreet
Nov-14-14 12:03PM[$$] Regional Bank Stocks Priced to Buy at
Nov-12-14 03:38PMPhoto Release -- Daniel A. Greene Joins Northfield Bank as Senior Vice President and Commercial Banking Lead GlobeNewswire
Nov-10-14 05:42AMWill Northfield Bancorp (NFBK) Crush Estimates at Its Next Earnings Report? Zacks
Oct-22-14 09:09PMNorthfield Bancorp, Inc. Announces Third Quarter 2014 Results GlobeNewswire
Oct-17-14 11:00AMPeople's United Reports In-Line Q3 Earnings, Revenues Down Zacks
Oct-15-14 09:13AM4 Small Bank CEOs Speak On The Future Of Opportunities In The Sector Benzinga
Oct-07-14 10:50AMBNY Mellon to Buy Cutwater Asset Management from MBIA Zacks
Sep-19-14 11:28AMExclusive: Northfield Bancorp, Inc. Top Executives On Growth, M&A And More Benzinga
Sep-15-14 10:50AMNorthfield Bancorp Hits 52-week High: Should You Buy? Zacks
Northfield Bancorp, Inc. operates as the holding company for Northfield Bank that provides a range of banking services primarily to individuals and corporate customers in Richmond and Kings Counties in New York, and Union and Middlesex Counties in New Jersey. The company's deposit products comprise savings accounts, such as money market, passbook, and statement savings; transaction accounts, including negotiable orders of withdrawal accounts and non-interest bearing demand accounts; certificates of deposit, such as individual retirement accounts; and brokered deposits. Its loan product portfolio includes one-to-four family residential real estate loans, construction and land loans, commercial and industrial loans, and home equity loans and lines of credit. The company also owns a real estate investment trust, which holds primarily mortgage loans and other real estate related investments. It serves customers through its home office located in Staten Island, New York; and 29 additional branch offices situated in Staten Island, Brooklyn, and the New Jersey counties of Union and Middlesex. Northfield Bancorp, Inc. was founded in 1887 and is based in Woodbridge, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patafio Frank P.DirectorNov 13Sale14.261,00014,260199,150Nov 14 08:54 AM
Jacobs William R.SVP & PAOOct 28Option Exercise7.0910,15672,00651,883Oct 30 11:58 AM
Patafio Frank P.DirectorAug 08Sale13.001,00013,004200,150Aug 08 02:12 PM
DePierro John JDirectorJul 29Sale13.011,50019,51582,605Jul 29 11:20 AM
Bowen John RDirectorJun 17Sale13.0410,000130,35432,675Jun 18 04:21 PM
CompanyNektar Therapeutics
Market Cap2.15BEPS (ttm)-0.51
P/E-EPS this Y6.70%
Forward P/E1044.37EPS next Y104.50%
PEG-EPS past 5Y-30.50%
P/S10.11EPS next 5Y53.60%
P/B45.16EPS Q/Q478.60%
Dividend-Sales Q/Q118.20%
Insider Own0.36%Inst Own92.90%
Insider Trans-Inst Trans3.99%
Short Float7.66%EarningsNov 06/a
Analyst Recom1.90Target Price17.56
Avg Volume1.32M52W Range10.10 - 15.96
Nov-26-14 07:34AMWill Nektar Therapeutics (NKTR) Continue to Surge Higher? Zacks
Nov-24-14 10:12AMFDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation PR Newswire
Nov-20-14 09:00AMNektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a PARP Inhibitor in BRCA1-deficient Cancer Model PR Newswire
Nov-17-14 06:12AMNektar Therapeutics (NKTR): An Off-the-Radar Potential Winner Zacks
Nov-14-14 01:04PMNEKTAR THERAPEUTICS Financials EDGAR Online Financials
Nov-10-14 07:08PM10-Q for Nektar Therapeutics Company Spotlight
Nov-10-14 11:20AMNektar Therapeutics Beats on Q3 Earnings and Revenues Zacks
Nov-07-14 06:08AMNEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-07-14 05:04AMNektar beats Street 3Q forecasts AP
Nov-06-14 04:20PMNEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline comprises drug candidates in therapeutic areas, including oncology, pain, anti-infectives, and immunology. The company's drug candidates in clinical development stage comprise naloxegol, an opioid antagonist, which has completed Phase III clinical trial for treating opioid-induced constipation; BAY41-6551 that is in Phase III clinical trial to treat gram-negative pneumonias; NKTR-181, which has completed Phase II clinical trial for chronic pain; and NKTR-171 that is in Phase I clinical trial to treat neuropathic pain. Its other product candidates comprise etirinotecan pegol, a topoisomerase I inhibitor, which is in Phase III clinical trial for metastatic breast cancer and in Phase II clinical trial for second-line metastatic colorectal cancer; and in combination with 5-fluorouracil/leucovorin to treat metastatic colorectal cancer that has completed Phase I clinical trial. In addition, the company offers preclinical drug candidates comprising opioid/NKTR-118 to treat chronic pain; NKTR-192 to treat acute pain; and NKTR-214, a cytokine immunostimulatory therapy to treat oncology. Nektar Therapeutics has collaboration with Bayer Healthcare LLC to develop BAY41-6551, which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB to develop and commercialize naloxegol and naloxegol fixed-dose combination program. Further, it has license, manufacturing, and supply agreements with Amgen Inc.; MAP Pharmaceuticals, Inc.; Merck & Co., Inc.; Ophthotech Corporation; Pfizer, Inc.; F. Hoffmann-La Roche Ltd (Roche), Regado Biosciences, Inc.; and UCB Pharma. The company was founded in 1990 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBIN HOWARD WPresident & CEONov 25Option Exercise14.52467,2006,783,744477,200Nov 26 05:41 PM
ROBIN HOWARD WPresident & CEONov 25Sale15.31467,2007,152,83210,000Nov 26 05:41 PM
Lingnau LutzDirectorNov 24Option Exercise8.8115,000132,15031,450Nov 26 05:39 PM
ROBIN HOWARD WPresident & CEONov 24Option Exercise14.52132,8001,928,256142,800Nov 26 05:41 PM
Labrucherie Gil MSVP & General CounselNov 24Option Exercise13.0210,500136,71014,251Nov 26 05:47 PM
CompanyCovenant Transportation Group, Inc.
Market Cap477.76MEPS (ttm)0.50
P/E54.26EPS this Y-14.60%
Forward P/E21.70EPS next Y27.55%
PEG10.85EPS past 5Y15.90%
P/S0.69EPS next 5Y5.00%
P/B3.96EPS Q/Q-7.70%
Dividend-Sales Q/Q4.00%
Insider Own31.80%Inst Own48.90%
Insider Trans1.12%Inst Trans-6.96%
Short Float1.75%EarningsOct 15/a
Analyst Recom1.50Target Price28.33
Avg Volume210.95K52W Range7.21 - 25.93
Nov-27-14 12:30PMJB Hunt Banks on Intermodal Growth, Fuel Price Woes Persist Zacks
Nov-25-14 02:17PMCOVENANT TRANSPORTATION GROUP INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Nov-24-14 07:37AMCovenant Transportation (CVTI) Shares March Higher, Can It Continue? Zacks
Nov-21-14 01:04PMCOVENANT TRANSPORTATION GROUP INC Financials EDGAR Online Financials
Nov-21-14 10:24AMCovenant Transport (CVTI) & Inteliquent (IQNT): Top Stocks to Add to Your Momentum Portfolio Zacks
Nov-21-14 06:17AMCovenant Transportation (CVTI) in Focus: Stock Up 5.3% Zacks
Nov-20-14 05:24PMCOVENANT TRANSPORTATION GROUP INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Nov-20-14 01:25PMIBD 50 Stocks Advance As Market Holds Gains at Investor's Business Daily
Nov-20-14 09:58AMStrong And Under The Radar Today: Covenant Transportation Group (CVTI) at TheStreet
Nov-15-14 07:07PM10-Q for Covenant Transportation Group, Inc. Company Spotlight
Covenant Transportation Group, Inc., together with its subsidiaries, offers truckload transportation and brokerage services in the continental United States. Its Asset-Based Truckload Services segment provides long haul, dedicated, temperature-controlled, and regional solo-driver services. The company also offers freight brokerage services directly, as well as through freight brokerage agents; less-than-truckload consolidation services; and accounts receivable factoring services. It serves transportation companies, such as freight forwarders, less-than-truckload carriers, and third-party logistics providers, as well as traditional truckload customers, including manufacturers, retailers, and food and beverage shippers. As of December 31, 2013, the company operated 2,688 tractors and 6,861 trailers. Covenant Transportation Group, Inc. was founded in 1994 and is headquartered in Chattanooga, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hough Samuel FExec VP & COO of SubsidiarySep 04Buy12.961,00012,96036,624Sep 09 04:40 PM
LOVIN RALPH H JRExecutive VP and SecretaryAug 22Sale13.531,32617,94185,089Aug 25 03:53 PM
LOVIN RALPH H JRExecutive VP and SecretaryMar 06Sale11.551,40916,27590,442Mar 06 05:42 PM
LOVIN RALPH H JRExecutive VP and SecretaryMar 03Sale10.052,65026,63393,349Mar 04 06:07 PM
TickerBDX [NYSE, S&P 500]
CompanyBecton, Dickinson and Company
IndustryMedical Instruments & Supplies
Market Cap27.10BEPS (ttm)6.01
P/E23.50EPS this Y28.50%
Forward P/E19.44EPS next Y6.91%
PEG3.24EPS past 5Y4.80%
P/S3.21EPS next 5Y7.27%
P/B5.05EPS Q/Q232.60%
Dividend1.54%Sales Q/Q4.80%
Insider Own0.10%Inst Own86.30%
Insider Trans-61.31%Inst Trans0.42%
Short Float3.96%EarningsNov 04/b
Analyst Recom2.30Target Price138.67
Avg Volume1.50M52W Range103.48 - 135.27
Nov-26-14 12:47PMBECTON DICKINSON & CO Files SEC form 10-K, Annual Report EDGAR Online
Nov-25-14 04:15PMBD to Present at the 26th Annual Piper Jaffray Healthcare Conference PR Newswire
Nov-25-14 01:06PMBecton Dickinson: CareFusion Buy Adding More To EPS at Investor's Business Daily
Nov-25-14 09:24AMBECTON DICKINSON & CO Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online
Nov-25-14 08:00AMBD Board Declares Dividend PR Newswire
Nov-24-14 12:30PMCare Fusion & Becton, Dickinson Hit Highs on Merger Progress Zacks
Nov-20-14 09:05AMBecton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction PR Newswire
Nov-20-14 07:22AMBritain begins review to speed access to new drugs Reuters
Nov-17-14 04:33AMCramer: Stocks That Stand Out TheStreet
Nov-14-14 02:34PMBECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial EDGAR Online
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; and generic prefilled injectables. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sichak StephenSenior Vice PresidentJun 12Option Exercise84.334,992420,97512,335Jun 12 04:38 PM
Sichak StephenSenior Vice PresidentJun 12Sale118.251,456172,1727,343Jun 12 04:38 PM
COHEN GARY MExecutive Vice PresidentJun 10Option Exercise78.0436,2302,827,37588,543Jun 11 01:51 PM
COHEN GARY MExecutive Vice PresidentJun 10Sale119.2412,4761,487,63870,386Jun 11 01:51 PM
SHERMAN JEFFREY SSr. VP and General CounselJun 09Option Exercise62.5016,4081,025,50044,176Jun 10 01:17 PM
1 2 3 4 5 6 ... 10 ... 20 next